Treatment of macrophages with CM (from CtBP1‐overexpressed NSCLC cells) led to a remarkable increase transcript of CD163, a TAM marker in comparison with the corresponding control group (Figure 5C). The gene discussed is CD163; the disease is non-small cell lung carcinoma.